- Home
- BMRC vs KRRO Comparison
BMRC vs KRRO Comparison
Compare BMRC & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRC
- KRRO
- Stock Information
- Founded
- BMRC 1989
- KRRO 2014
- Country
- BMRC United States
- KRRO United States
- Employees
- BMRC N/A
- KRRO N/A
- Industry
- BMRC Major Banks
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- BMRC Finance
- KRRO Health Care
- Exchange
- BMRC Nasdaq
- KRRO Nasdaq
- Market Cap
- BMRC 394.5M
- KRRO 209.6M
- IPO Year
- BMRC N/A
- KRRO 2019
- Fundamental
- Price
- BMRC $22.29
- KRRO $24.66
- Analyst Decision
- BMRC Strong Buy
- KRRO Strong Buy
- Analyst Count
- BMRC 3
- KRRO 7
- Target Price
- BMRC $28.00
- KRRO $133.83
- AVG Volume (30 Days)
- BMRC 74.0K
- KRRO 63.7K
- Earning Date
- BMRC 04-28-2025
- KRRO 03-25-2025
- Dividend Yield
- BMRC 4.46%
- KRRO N/A
- EPS Growth
- BMRC N/A
- KRRO N/A
- EPS
- BMRC N/A
- KRRO N/A
- Revenue
- BMRC $67,983,000.00
- KRRO N/A
- Revenue This Year
- BMRC $63.26
- KRRO N/A
- Revenue Next Year
- BMRC $9.68
- KRRO N/A
- P/E Ratio
- BMRC N/A
- KRRO N/A
- Revenue Growth
- BMRC N/A
- KRRO N/A
- 52 Week Low
- BMRC $14.11
- KRRO $18.50
- 52 Week High
- BMRC $27.11
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- BMRC 30.48
- KRRO 42.78
- Support Level
- BMRC $21.89
- KRRO $18.50
- Resistance Level
- BMRC $24.71
- KRRO $23.18
- Average True Range (ATR)
- BMRC 0.85
- KRRO 2.05
- MACD
- BMRC -0.25
- KRRO 0.32
- Stochastic Oscillator
- BMRC 12.16
- KRRO 66.31
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.